* Dynavax announces FDA acceptance for review of Biologics License Application and PDUFA action date for HEPLISAV-b(tm) Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1 646…
The post BRIEF-Dynavax announces FDA acceptance for review of Biologics License Application and PDUFA action date for HEPLISAV-b(tm) appeared first on NASDAQ.